Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Thomas Gad. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Veja os Insiders com Maior Classificação
Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Thomas Gad reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
US:YMAB / Y-mAbs Therapeutics, Inc. CHIEF BUSINESS OFFICER, Director 0
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Thomas Gad. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Thomas Gad conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual		 Preço
da Ação		 Valor
da Transação		 Valor
Restante
2025-09-18 2025-09-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		U - Other -60,000 0 -100.00 8.60 -516,000
2025-09-18 2025-09-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		U - Other -67,681 0 -100.00 8.60 -582,057
2025-09-18 2025-09-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		D - Sale to Issuer -60,235 0 -100.00
2025-09-18 2025-09-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		U - Other -245,486 0 -100.00 8.60 -2,111,180
2025-06-05 2025-06-03 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise 103,000 305,721 50.81 2.00 206,000 611,442
2025-03-11 2025-03-07 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -10,810 202,721 -5.06 5.23 -56,536 1,060,231
2025-01-22 2025-01-17 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		A - Award 32,000 213,531 17.63
2024-09-20 2024-09-19 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise 22,831 181,531 14.39 4.38 100,000 795,106
2024-09-17 2024-09-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -30,000 67,681 -30.71 12.97 -389,100 877,823
2024-09-17 2024-09-13 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -65,000 97,681 -39.96 13.47 -875,550 1,315,763
2024-06-11 2024-06-11 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -35,000 162,681 -17.71 12.00 -420,000 1,952,172
2024-06-11 2024-06-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -35,000 197,681 -15.04 12.03 -421,050 2,378,102
2024-05-23 2024-05-23 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -7,351 232,681 -3.06 13.00 -95,563 3,024,853
2024-05-23 2024-05-21 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -25,000 240,032 -9.43 12.00 -300,000 2,880,384
2024-03-07 2024-03-05 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -3,900 158,700 -2.40 16.44 -64,116 2,609,028
2024-01-22 2024-01-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		A - Award 22,100 162,600 15.73
2023-12-26 2023-12-21 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise 50,000 140,500 55.25 2.00 100,000 281,000
2023-12-15 2023-12-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -50,000 265,032 -15.87 6.61 -330,500 1,751,862
2023-12-15 2023-12-14 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -50,000 315,032 -13.70 6.83 -341,500 2,151,669
2023-12-15 2023-12-13 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -50,000 365,032 -12.05 6.58 -329,000 2,401,911
2023-11-22 2023-11-21 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -75,000 415,032 -15.31 5.31 -397,988 2,202,367
2023-11-22 2023-11-20 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -75,000 490,032 -13.27 5.30 -397,395 2,596,484
2023-01-19 2023-01-17 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		A - Award 40,500 90,500 81.00
2022-05-19 2022-05-18 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		A - Award 60,000 60,000
2022-02-09 2022-02-09 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -64,276 565,032 -10.21 6.96 -447,117 3,930,476
2022-02-09 2022-02-08 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -125,863 629,308 -16.67 7.01 -882,891 4,414,407
2022-02-09 2022-02-07 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -91,031 755,171 -10.76 7.59 -691,180 5,733,862
2022-02-07 2022-02-04 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -101,104 846,202 -10.67 7.70 -778,531 6,516,009
2022-02-07 2022-02-03 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -35,060 947,306 -3.57 7.90 -277,027 7,485,138
2022-02-03 2022-02-01 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -8,000 153,000 -4.97
2022-02-03 2022-02-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -8,000 50,000 -13.79 10.15 -81,161 507,255
2022-02-03 2022-02-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise 8,000 58,000 16.00 2.00 16,000 116,000
2022-01-26 2022-01-24 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -55,783 982,366 -5.37 10.96 -611,281 10,764,963
2022-01-26 2022-01-24 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -32,272 1,038,149 -3.01 10.07 -325,131 10,459,040
2022-01-24 2022-01-21 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -20,184 1,070,421 -1.85 11.35 -229,103 12,150,028
2022-01-24 2022-01-21 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -50,134 1,090,605 -4.39 10.51 -526,713 11,458,005
2022-01-24 2022-01-20 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -112,767 1,140,739 -9.00 11.33 -1,277,289 12,920,923
2022-01-20 2022-01-19 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -69,414 1,253,506 -5.25 10.89 -756,092 13,653,814
2022-01-20 2022-01-18 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -8,000 161,000 -4.73
2022-01-20 2022-01-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -400 1,322,920 -0.03 11.46 -4,584 15,160,663
2022-01-20 2022-01-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -8,000 50,000 -13.79 11.54 -92,314 576,965
2022-01-20 2022-01-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise 8,000 58,000 16.00 2.00 16,000 116,000
2021-12-16 2021-12-14 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		A - Award 110,000 110,000
2021-12-16 2021-12-14 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		G - Gift 60,000 1,383,320 4.53
2021-12-16 2021-12-14 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		G - Gift -60,000 1,323,320 -4.34
2021-12-08 2021-12-07 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -10,000 1,383,320 -0.72 17.58 -175,832 24,323,192
2021-12-08 2021-12-06 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -4,000 1,393,320 -0.29 16.50 -65,982 22,983,510
2021-12-08 2021-12-06 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -40,000 1,397,320 -2.78 16.48 -659,260 23,029,930
2021-12-01 2021-11-30 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,437,320 -0.28 16.98 -67,912 24,402,963
2021-12-01 2021-11-30 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -7,770 1,441,320 -0.54 17.04 -132,433 24,566,002
2021-12-01 2021-11-30 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -12,800 1,449,090 -0.88 17.11 -218,947 24,786,974
2021-12-01 2021-11-30 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -600 1,461,890 -0.04 16.94 -10,166 24,769,241
2021-12-01 2021-11-29 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -22,437 1,462,490 -1.51 17.16 -385,026 25,096,767
2021-11-26 2021-11-23 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -50,000 169,000 -22.83
2021-11-26 2021-11-23 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -50,000 50,000 -50.00 17.06 -852,850 852,850
2021-11-26 2021-11-23 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise 50,000 100,000 100.00 2.00 100,000 200,000
2021-11-18 2021-11-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,484,927 -0.27 19.33 -77,302 28,696,957
2021-11-01 2021-10-29 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,488,927 -0.27 24.82 -99,261 36,948,021
2021-10-19 2021-10-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,492,927 -0.27 27.20 -108,799 40,607,316
2021-10-04 2021-09-30 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,496,927 -0.27 28.26 -113,054 42,308,546
2021-09-17 2021-09-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,500,927 -0.27 33.64 -134,579 50,498,239
2021-09-07 2021-09-07 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -50,000 219,000 -18.59
2021-09-07 2021-09-07 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise 50,000 50,000 2.00 100,000 100,000
2021-09-07 2021-09-02 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -50,000 1,504,927 -3.22 33.18 -1,658,915 49,930,919
2021-08-17 2021-08-17 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -1,779 1,554,927 -0.11 28.96 -51,527 45,036,906
2021-08-17 2021-08-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -22,111 1,556,706 -1.40 29.33 -648,527 45,658,965
2021-08-17 2021-08-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,578,817 -0.25 29.14 -116,544 46,000,412
2021-08-17 2021-08-13 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -1,110 1,582,817 -0.07 31.01 -34,426 49,089,645
2021-08-05 2021-08-03 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,583,927 -0.25 33.73 -134,927 53,428,709
2021-07-21 2021-07-20 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,587,927 -0.25 32.47 -129,875 51,558,084
2021-07-08 2021-07-07 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,591,927 -0.25 31.87 -127,465 50,728,664
2021-07-02 2021-06-30 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,595,927 -0.25 33.86 -135,446 54,040,323
2021-06-15 2021-06-14 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,599,927 -0.25 35.80 -143,217 57,284,266
2021-06-01 2021-05-28 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,603,927 -0.25 36.95 -147,813 59,270,396
2021-05-20 2021-05-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,607,927 -0.25 34.07 -136,290 54,785,932
2021-04-28 2021-04-26 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -7,000 269,000 -2.54
2021-04-28 2021-04-26 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -7,000 0 -100.00 27.96 -195,730
2021-04-28 2021-04-26 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise X 7,000 7,000 2.00 14,000 14,000
2021-04-14 2021-04-12 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -7,000 276,000 -2.47
2021-04-14 2021-04-12 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,611,927 -0.25 26.60 -106,388 42,872,422
2021-04-14 2021-04-12 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -7,000 0 -100.00 26.61 -186,253
2021-04-14 2021-04-12 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise X 7,000 7,000 2.00 14,000 14,000
2021-04-05 2021-04-01 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -9,000 283,000 -3.08
2021-04-05 2021-04-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -6,000 1,615,927 -0.37 30.27 -181,615 48,912,818
2021-04-05 2021-04-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -9,000 0 -100.00 30.26 -272,331
2021-04-05 2021-04-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise X 9,000 9,000 2.00 18,000 18,000
2021-03-17 2021-03-15 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -7,000 292,000 -2.34
2021-03-17 2021-03-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 1,621,927 -0.25 36.78 -147,102 59,647,176
2021-03-17 2021-03-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -7,000 0 -100.00 36.79 -257,554
2021-03-17 2021-03-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise X 7,000 7,000 2.00 14,000 14,000
2021-03-12 2021-03-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		J - Other 1,029,927 1,625,927 172.81
2021-03-03 2021-03-01 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -9,000 299,000 -2.92
2021-03-03 2021-03-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -6,000 596,000 -1.00 35.50 -213,029 21,160,861
2021-03-03 2021-03-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -9,000 0 -100.00 35.51 -319,611
2021-03-03 2021-03-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise X 9,000 9,000 2.00 18,000 18,000
2021-02-18 2021-02-16 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -7,000 308,000 -2.22
2021-02-18 2021-02-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 602,000 -0.66 47.09 -188,367 28,349,203
2021-02-18 2021-02-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -7,000 0 -100.00 47.08 -329,556
2021-02-18 2021-02-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise X 7,000 7,000 2.00 14,000 14,000
2021-02-03 2021-02-01 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -7,000 315,000 -2.17
2021-02-03 2021-02-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 606,000 -0.66 41.97 -167,888 25,435,032
2021-02-03 2021-02-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -7,000 0 -100.00 41.99 -293,897
2021-02-03 2021-02-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise X 7,000 7,000 2.00 14,000 14,000
2021-01-21 2021-01-19 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -7,000 322,000 -2.13
2021-01-21 2021-01-19 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 610,000 -0.65 46.56 -186,230 28,400,136
2021-01-21 2021-01-19 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -7,000 0 -100.00 46.51 -325,563
2021-01-21 2021-01-19 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise X 7,000 7,000 2.00 14,000 14,000
2021-01-07 2021-01-05 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -7,000 329,000 -2.08
2021-01-07 2021-01-05 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 614,000 -0.65 49.31 -197,248 30,277,568
2021-01-07 2021-01-05 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -7,000 0 -100.00 49.36 -345,509
2021-01-07 2021-01-05 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise X 7,000 7,000 2.00 14,000 14,000
2020-12-30 2020-12-28 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -7,000 336,000 -2.04
2020-12-30 2020-12-28 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -7,000 0 -100.00 51.98 -363,833
2020-12-30 2020-12-28 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise X 7,000 7,000 2.00 14,000 14,000
2020-12-17 2020-12-16 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -7,000 343,000 -2.00
2020-12-17 2020-12-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -7,000 0 -100.00 53.01 -371,065
2020-12-17 2020-12-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise X 7,000 7,000 2.00 14,000 14,000
2020-12-16 2020-12-14 4 VYMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 618,000 -0.64 52.89 -211,546 32,683,795
2020-12-16 2020-12-15 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		A - Award 91,450 91,450
2020-12-14 2020-12-11 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -50,000 0 -100.00 51.17 -2,558,640
2020-12-14 2020-12-11 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise 50,000 50,000 2.00 100,000 100,000
2020-12-14 2020-12-10 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -50,000 350,000 -12.50
2020-12-14 2020-12-10 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -50,000 350,000 -12.50
2020-12-14 2020-12-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -50,000 0 -100.00 50.75 -2,537,620
2020-12-14 2020-12-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise 50,000 50,000 2.00 100,000 100,000
2020-12-02 2020-12-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 622,000 -0.64 51.42 -205,685 31,984,049
2020-11-17 2020-11-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 626,000 -0.63 46.17 -184,672 28,901,105
2020-11-05 2020-11-02 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 630,000 -0.63 43.69 -174,769 27,526,086
2020-10-19 2020-10-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 634,000 -0.63 39.15 -156,604 24,821,671
2020-10-02 2020-10-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 638,000 -0.62 38.88 -155,524 24,806,142
2020-09-17 2020-09-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 642,000 -0.62 40.81 -163,225 26,197,580
2020-09-15 2020-09-14 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -22,569 450,000 -4.78
2020-09-15 2020-09-14 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -22,569 0 -100.00 41.00 -925,426
2020-09-15 2020-09-14 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise 22,569 22,569 2.00 45,138 45,138
2020-09-15 2020-09-11 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -13,571 472,569 -2.79
2020-09-15 2020-09-11 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -13,571 0 -100.00 40.33 -547,331
2020-09-15 2020-09-11 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise 13,571 13,571 2.00 27,142 27,142
2020-09-15 2020-09-10 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		M - Exercise -13,860 486,140 -2.77
2020-09-15 2020-09-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -13,860 0 -100.00 41.58 -576,360
2020-09-15 2020-09-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		M - Exercise 13,860 13,860 2.00 27,720 27,720
2020-09-02 2020-09-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 646,000 -0.62 41.60 -166,390 26,872,050
2020-08-19 2020-08-17 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 650,000 -0.61 40.35 -161,392 26,226,200
2020-08-13 2020-08-12 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -13,000 654,000 -1.95 39.51 -513,636 25,839,867
2020-08-13 2020-08-11 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -37,000 667,000 -5.26 40.06 -1,482,042 26,716,818
2020-08-05 2020-08-03 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 704,000 -0.56 36.51 -146,026 25,700,576
2020-07-17 2020-07-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 708,000 -0.56 40.06 -160,229 28,360,568
2020-07-06 2020-07-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 712,000 -0.56 42.04 -168,178 29,935,684
2020-06-16 2020-06-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 716,000 -0.56 43.45 -173,811 31,112,205
2020-06-05 2020-06-04 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 720,000 -0.55 41.61 -166,444 29,959,848
2020-05-29 2020-05-27 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -50,000 724,000 -6.46 39.01 -1,950,460 28,242,661
2020-05-20 2020-05-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 774,000 -0.51 39.65 -158,596 30,688,326
2020-05-14 2020-05-12 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -50,000 778,000 -6.04 39.04 -1,951,935 30,372,109
2020-05-05 2020-05-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 828,000 -0.48 32.35 -129,404 26,786,711
2020-04-15 2020-04-13 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 832,000 -0.48 29.43 -117,711 24,483,930
2020-03-18 2020-03-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 836,000 -0.48 18.01 -72,041 15,056,527
2020-03-04 2020-03-02 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 840,000 -0.47 29.18 -116,713 24,509,772
2020-02-20 2020-02-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 844,000 -0.47 32.78 -131,133 27,669,021
2020-02-11 2020-02-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 848,000 -0.47 33.03 -132,121 28,009,610
2020-01-29 2020-01-27 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 852,000 -0.47 35.06 -140,224 29,867,627
2020-01-15 2020-01-13 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 856,000 -0.47 30.90 -123,612 26,452,968
2020-01-09 2020-01-07 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		A - Award 130,000 130,000
2019-12-31 2019-12-30 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		J - Other -201 1,030,356 -0.02
2019-12-17 2019-12-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 860,000 -0.46 31.54 -126,176 27,127,926
2019-12-17 2019-12-13 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		G - Gift -8,000 864,000 -0.92
2019-12-04 2019-12-02 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 872,000 -0.46 32.48 -129,930 28,324,827
2019-11-19 2019-11-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 876,000 -0.45 28.41 -113,658 24,891,014
2019-11-05 2019-11-04 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 880,000 -0.45 30.10 -120,418 26,491,960
2019-10-22 2019-10-21 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 884,000 -0.45 27.59 -110,351 24,387,527
2019-10-08 2019-10-07 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 888,000 -0.45 25.21 -100,848 22,388,256
2019-09-17 2019-09-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 892,000 -0.45 30.59 -122,376 27,289,759
2019-09-05 2019-09-03 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 896,000 -0.44 25.77 -103,081 23,090,099
2019-08-20 2019-08-19 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 900,000 -0.44 27.70 -110,805 24,931,080
2019-08-06 2019-08-05 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 904,000 -0.44 21.78 -87,106 19,685,866
2019-07-23 2019-07-22 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 908,000 -0.44 22.54 -90,177 20,470,134
2019-07-10 2019-07-08 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 912,000 -0.44 22.40 -89,592 20,426,885
2019-06-25 2019-06-24 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 916,000 -0.43 21.77 -87,098 19,945,350
2019-06-11 2019-06-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 920,000 -0.43 22.79 -91,166 20,968,272
2019-06-04 2019-06-03 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -4,000 924,000 -0.43 20.03 -80,121 18,507,997
2019-05-29 2019-05-28 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -6,000 928,000 -0.64 20.21 -121,252 18,753,674
2019-05-14 2019-05-13 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale X -6,000 934,000 -0.64 20.61 -123,647 19,247,779
2019-04-11 2019-04-11 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -150,000 940,000 -13.76 25.80 -3,870,000 24,252,000
2019-04-11 2019-04-09 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -800 1,090,000 -0.07 26.93 -21,545 29,355,444
2019-04-11 2019-04-09 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		S - Sale -99,200 1,090,800 -8.34 26.02 -2,581,184 28,382,616
2018-12-13 2018-12-11 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy) 		A - Award 107,500 107,500
2018-09-20 3 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		3,410,557
2018-09-20 3 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		3,251,114
2018-09-20 3 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		3,410,557
2018-09-20 3 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		3,251,114
2018-09-20 3 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		3,410,557
2018-09-20 3 YMAB Y-mAbs Therapeutics, Inc.
Common Stock 		3,251,114
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)